196 related articles for article (PubMed ID: 38571422)
1. Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention.
Anagnostou V; Velculescu VE
Cancer Discov; 2024 Apr; 14(4):615-619. PubMed ID: 38571422
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy Applications in the Clinic.
Chen D; Xu T; Wang S; Chang H; Yu T; Zhu Y; Chen J
Mol Diagn Ther; 2020 Apr; 24(2):125-132. PubMed ID: 31919754
[TBL] [Abstract][Full Text] [Related]
4. Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring.
Martins I; Ribeiro IP; Jorge J; Gonçalves AC; Sarmento-Ribeiro AB; Melo JB; Carreira IM
Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33673461
[TBL] [Abstract][Full Text] [Related]
5. dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A; Calabuig-Fariñas S; Obrador-Hevia A; Blasco A; Fernández-Díaz A; Sirera R; Camps C; Jantus-Lewintre E
Expert Rev Mol Diagn; 2021 Jan; 21(1):3-15. PubMed ID: 33305634
[No Abstract] [Full Text] [Related]
6. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
Barlebo Ahlborn L; Østrup O
APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Croessmann S; Park BH
Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
[TBL] [Abstract][Full Text] [Related]
8. Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.
Chen K; Shields MD; Chauhan PS; Ramirez RJ; Harris PK; Reimers MA; Zevallos JP; Davis AA; Pellini B; Chaudhuri AA
Mol Diagn Ther; 2021 Nov; 25(6):757-774. PubMed ID: 34725800
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
Kilgour E; Rothwell DG; Brady G; Dive C
Cancer Cell; 2020 Apr; 37(4):485-495. PubMed ID: 32289272
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
11. Advances in liquid biopsy approaches for early detection and monitoring of cancer.
Babayan A; Pantel K
Genome Med; 2018 Mar; 10(1):21. PubMed ID: 29558971
[TBL] [Abstract][Full Text] [Related]
12. Molecular screening of head neck cancer.
Mali SB
Oral Oncol; 2023 Sep; 144():106481. PubMed ID: 37399708
[TBL] [Abstract][Full Text] [Related]
13. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
14. Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection.
Cheng AP; Landau DA
Med; 2021 Oct; 2(10):1114-1116. PubMed ID: 35590202
[TBL] [Abstract][Full Text] [Related]
15. Somatic copy number aberrations in metastatic patients: The promise of liquid biopsies.
Baldacchino S; Grech G
Semin Cancer Biol; 2020 Feb; 60():302-310. PubMed ID: 31891778
[TBL] [Abstract][Full Text] [Related]
16. Current and future perspectives of liquid biopsies in genomics-driven oncology.
Heitzer E; Haque IS; Roberts CES; Speicher MR
Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA: current challenges for clinical utility.
Dang DK; Park BH
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703177
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers.
Alese OB; Cook N; Ortega-Franco A; Ulanja MB; Tan L; Tie J
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-20. PubMed ID: 35471832
[TBL] [Abstract][Full Text] [Related]
19. Clinical implementation and current advancement of blood liquid biopsy in cancer.
Watanabe K; Nakamura Y; Low SK
J Hum Genet; 2021 Sep; 66(9):909-926. PubMed ID: 34088974
[TBL] [Abstract][Full Text] [Related]
20. Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer.
Al-Obeidi E; Riess JW; Malapelle U; Rolfo C; Gandara DR
Hematol Oncol Clin North Am; 2023 Jun; 37(3):475-487. PubMed ID: 37024388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
